Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
1
Bullish
9
Bearish
36
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
1
Bullish
9
Bearish
4
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Laxmi Organic Industries is an integrated Indian chemicals manufacturer focused on Acetyl Intermediates and Specialty Intermediates, producing ethyl acetate, acetic acid and diketene derivatives along with a newly commissioned electrochemical fluorination platform and a multi‑phase Dahej expansion to increase specialty capacity and downstream integration.
Q1 FY27 results were robust: consolidated revenue of INR9,683 million (up 40% YoY, 32% sequentially) and EBITDA of INR1,143 million (up 272% YoY), driven by a combination of ~10% volume growth and strong price/mix realization amid raw material volatility and supply dislocations.
Management reports Dahej Phase 2 nearing mechanical completion with ~85% of Phase 2 capex expected to be capitalised in Q2, full ramp targeted across Q4 FY27 and FY28, and full-year capex guidance of INR125–150 crore for FY27; term debt peaked around INR6,100 million and net debt/equity stands near 0.3x.
Laxmi has completed strategic M&A and capability builds — Clariant diketene acquisition, YCPL integration, Miteni asset acquisition and commissioning of India’s first commercial electrochemical fluorination (ECF) platform — positioning the company for higher‑margin fluorochemical and specialty opportunities.
Key risks include severe feedstock price volatility (acetic acid and methanol spikes), logistics and geopolitical disruptions (West Asia crisis, Red Sea, typhoons affecting shipping), and customer qualification timing for new Dahej products which affect near-term ramp and margin realization.
Chemicals & Petrochemicals
Specialty Chemicals
4,185 Cr
High Risk
33.3
35.0
0.9
2.1
204.95
107.45
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 04, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stockLaxmi Organic Industries Ltd (LXCHEM) is currently trading at 150.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Laxmi Organic Industries is an integrated Indian chemicals manufacturer focused on Acetyl Intermediates and Specialty Intermediates, producing ethyl acetate, acetic acid and diketene derivatives along with a newly commissioned electrochemical fluorination platform and a multi‑phase Dahej expansion to increase specialty capacity and downstream integration. Q1 FY27 results were robust: consolidated revenue of INR9,683 million (up 40% YoY, 32% sequentially) and EBITDA of INR1,143 million (up 272% YoY), driven by a combination of ~10% volume growth and strong price/mix realization amid raw material volatility and supply dislocations. Management reports Dahej Phase 2 nearing mechanical completion with ~85% of Phase 2 capex expected to be capitalised in Q2, full ramp targeted across Q4 FY27 and FY28, and full-year capex guidance of INR125–150 crore for FY27; term debt peaked around INR6,100 million and net debt/equity stands near 0.3x. Laxmi has completed strategic M&A and capability builds — Clariant diketene acquisition, YCPL integration, Miteni asset acquisition and commissioning of India’s first commercial electrochemical fluorination (ECF) platform — positioning the company for higher‑margin fluorochemical and specialty opportunities. Key risks include severe feedstock price volatility (acetic acid and methanol spikes), logistics and geopolitical disruptions (West Asia crisis, Red Sea, typhoons affecting shipping), and customer qualification timing for new Dahej products which affect near-term ramp and margin realization.
Over the past 52 weeks, Laxmi Organic Industries Ltd has traded between a low of ₹107.45 and a high of ₹204.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Laxmi Organic Industries Ltd has a market capitalization of approximately 4,185.40. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Laxmi Organic Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4,185.40 Cr, Laxmi Organic Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Laxmi Organic Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Laxmi Organic Industries Ltd is 33.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The dataset shows Total Revenue of ₹692.93 crore for the quarter ended Jun 2025 and Net Income (PAT) of ₹21.39 crore.
The company informed BSE that the board meeting is scheduled for May 21, 2026 to consider and approve audited financial results for the quarter and year ended March 31, 2026.
The IPO opened on March 15, 2021 and closed on March 17, 2021.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
5738.10 | 4,325 Cr | 42.59 | 4.17 | 0.44 | 8.43 | 12.26 | 7.42 | ||
713.05 | 4,220 Cr | 96.75 | 9.43 | 0.16 | 0.00 | 0.00 | — | ||
150.60 | 4,185 Cr | 33.30 | 2.11 | 0.20 | 4.00 | 4.35 | 3.65 | ||
3328.50 | 4,013 Cr | 69.59 | 9.04 | 0.02 | 5.69 | 8.71 | 4.99 | ||
897.70 | 3,873 Cr | 14.29 | 1.74 | 0.56 | 14.94 | 14.69 | 7.73 | ||
562.75 | 3,788 Cr | 25.31 | 3.54 | 0.05 | 13.31 | 14.64 | 7.17 | ||
1572.10 | 3,677 Cr | 58.45 | 4.51 | 0.13 | 7.72 | 9.23 | 5.62 | ||
| Median: 7 Co. | — | 897.70 | 4,013 Cr | 42.59 | 4.17 | 0.16 | 7.72 | 9.23 | 6.40 |
